Shivering and changes in body temperature in patients undergoing operation for delivery of baby(cesarean section) under spinal anesthesia with a drug bupivacaine(local anesthetics)vs bupivacaine and fentanyl(opioid pain killer).
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: null- Pregnant women above 18 years of age of physical status ASA I and II scheduled for cesarean delivery under spinal anesthesia.
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant women above 18 years of age of physical status ASA I & II scheduled for cesarean delivery under spinal anesthesia.
Exclusion Criteria
1.Patients presenting with fever or shivering.
2.Placenta Previa and APH.
3.Obstetric or maternal condition and co-morbidities which may require spinal drug administration different from the study protocol (e.g. short stature, expected longer duration of surgery due to uterine abnormalities, hypertensive disorder of pregnancy, etc.)
4.Known allergy to drugs being used.
5.Patientâ??s refusal for spinal anesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the number of patients who developed shivering and the grade of shivering.Timepoint: Shivering will be noted intraoperatively with respect to time of spinal anaesthesia and baby delivery and 30 minutes post-operatively.The time of baby delivery, time of onset of shivering and grade of severity depending on scale will be recorded along with the body temperature.
- Secondary Outcome Measures
Name Time Method 1. Temperature changes from before administration of spinal to end-operative period in both the groups. <br/ ><br> 2. The number of patients receiving Inj. Pethidine as rescue for shivering in both the groups. <br/ ><br> 3. The time when shivering develops with respect to spinal and baby delivery and temperature at the onset of shivering. <br/ ><br>Timepoint: 1.Temperature values will be noted every 10 minutes. <br/ ><br>2.Injection Pethidine 25 mg will be administered intravenously for moderate and severe shivering and its requirement will be noted. <br/ ><br>3.The time of baby delivery, time of onset of shivering and grade of severity depending on scale will be recorded along with the body temperature.